MOL62.75

Meghmani Organics Limited

· Chemicals
₹ CrorePeersIPLPUNJABCHEMINSECTICIDASTECBHARATRASDHARMAJGSPCROPADVANCEMcap ₹1,596 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation92.2108.1119.0
+ Finance Costs46.469.091.9
+ Interest Income-0.8-0.6-4.3
+ Dividend Income-11.5-3.6-0.0
+ Unrealised FX (Gain) / Loss5.9-1.7-23.8
+ Other Non-cash Items1.50.8-4.9
+ Other — Cash Effects are Investing / Financing-1.31.41.0
Changes in Working Capital
+ Inventories128.8-81.870.5
+ Trade Receivables — Current82.8-138.6-74.6
+ Other Financial Assets — Current-2.041.04.2
+ Other Financial Assets — Non-current5.8-1.62.0
+ Other Current Assets-0.325.950.9
+ Other Non-current Assets-2.2-28.3-35.2
+ Trade Payables — Current45.363.2-12.4
+ Other Financial Liabilities — Current-14.21.84.2
+ Other Financial Liabilities — Non-current-0.2-0.2-0.1
+ Other Current Liabilities-1.04.5-10.3
+ Provisions — Non-current2.51.710.0
Cash from Operating Activities
Profit Before Tax (per I/S)-121.29.562.0104.7
+ Total Adjustments (incl. Working Capital)377.960.8187.9
Cash from Operations (pre-tax)256.870.3249.9
+ Income Taxes Paid7.14.028.2
Cash from Operating Activities249.766.2221.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)266.288.945.1
+ Disp of Fixed Assets2.22.81.1
+ Sale of Investments (Equity / Debt)55.095.00.0
+ Dividends Received — Investing15.97.73.2
+ Interest Received — Investing0.73.64.3
+ Other Inflows / (Outflows) — Investing14.010.7-1.9
Cash from Investing Activities-178.431.0-38.3
Cash from Financing Activities
+ Proceeds from Borrowings157.562.53.8
+ Repayment of Borrowings143.371.7107.3
+ Payment of Lease Liabilities0.01.80.2
+ Payment of Finance Lease Liabilities1.8
+ Interest Paid62.30.086.7
+ Dividends Paid35.60.00.0
+ Income Taxes (Paid) / Refund — Financing0.080.30.0
Cash from Financing Activities-85.5-91.4-190.3
Net Changes in Cash (pre-FX)-14.25.8-6.9
Net Changes in Cash-14.25.8-6.9
Closing Cash16.9
Reference Items
EBITDA-20.3142.7176.4207.5
EBITDA Margin %-1.296.868.129.86
Free Cash Flow (CFO − Capex)-16.5-22.7176.7176.7
Free Cash Flow to Equity-28.6-13.1
Free Cash Flow per Basic Share-0.65-0.896.956.95
Price to Free Cash Flow9.03
Cash Flow to Net Income-2.35-6.257.72
Cash Paid for Taxes7.14.028.2
Cash Paid for Interest62.30.086.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.